Thomas S. Griffith, Thomas A. Ferguson  Immunity 

Slides:



Advertisements
Similar presentations
Activation of T Lymphocytes
Advertisements

CMV and the Art of Memory Maintenance
Antigen-Primed CD8+ T Cells Call DCs for Back Up
T Cell Death and Transplantation Tolerance
Cytokines, Skin, and Smallpox–A New Link to an Antimicrobial Peptide
Bridget A. Robinson, Timothy J. Nice  Immunity 
An Activation Marker Finds a Function
Differentiation and Functions of CD8+ Effector T Cells
The Leptin Connection: Regulatory T Cells and Autoimmunity
Memory: The Incomplete Unhappening of Differentiation
TCF-1 Flips the Switch on Eomes
Toll-like Receptors Keep Antigen Sorting on the Right Track
Eos, Goddess of Treg Cell Reprogramming
Some DCs Are “B”etter Immunity
Treg's Alter Ego: An Accessory in Tumor Killing
Megan E. Daly, MD, Arta M. Monjazeb, MD, PhD, Karen Kelly, MD 
Malaria Vaccine Design: Immunological Considerations
Loss of CD47 Makes Dendritic Cells See Red
Chronic Infections Capture Little Attention of the Masses
Understanding Immunosuppression after Sepsis
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
miR-155-SOCS1 as a Functional Axis: Satisfying the Burden of Proof
Checks and Balances: IL-23 in the Intestine
Ana C. Anderson, Nicole Joller, Vijay K. Kuchroo  Immunity 
Dendritic Cells Break Bonds to Tolerize
Intracellular Pathogens and CD8+ Dendritic Cells: Dangerous Liaisons
Arming Treg Cells at the Inflammatory Site
Successful and Maladaptive T Cell Aging
Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy  Steven G. Deeks, Bruce D. Walker 
Chronic Infections Capture Little Attention of the Masses
Volume 32, Issue 4, Pages (April 2010)
BTLA+ Dendritic Cells: The Regulatory T Cell Force Awakens
Innate Cells and T Helper 2 Cell Immunity in Airway Inflammation
Tilo Biedermann, Martin Röcken, José M. Carballido 
Thomas R. Malek, Iris Castro  Immunity 
Yasmine Belkaid, Guillaume Oldenhove  Immunity 
Maria A. Curotto de Lafaille, Juan J. Lafaille  Immunity 
Regulatory T Cells and Immune Tolerance
Immunology of Food Allergy
Designing Vaccines Based on Biology of Human Dendritic Cell Subsets
Volume 33, Issue 4, Pages (October 2010)
Old Meets New: The Interaction Between Innate and Adaptive Immunity
The Role of TIM-4 in Food Allergy
Decoding Cell Death Signals in Inflammation and Immunity
From Vanilla to 28 Flavors: Multiple Varieties of T Regulatory Cells
Deciphering and Reversing Tumor Immune Suppression
DC-SIGN: The Strange Case of Dr. Jekyll and Mr. Hyde
Volume 30, Issue 2, Pages (February 2009)
Cigarette Smoke Resets the Alarmin IL-33 in COPD
IL-7 Knocks the Socs Off Chronic Viral Infection
IL-22 from T Cells: Better Late than Never
Professional Differences in Antigen Presentation to iNKT Cells
Inflaming the CD8+ T Cell Response
Regulatory T Cells: Context Matters
Regulatory B Cells: Origin, Phenotype, and Function
Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell Ties
Regulatory T Cells in Asthma
Peripheral Tolerance of CD8 T Lymphocytes
The Biology of Intestinal Immunoglobulin A Responses
Vaccines for Lung Cancer
Volume 32, Issue 4, Pages (April 2010)
Even Neurons Are Excited by Th17 Cells
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Jacques Banchereau, Virginia Pascual  Immunity 
Some DCs Are “B”etter Immunity
At 17, In-10's Passion Need Not Inflame
Dendritic Cells Decide CD8+ T Cell Fate
TCF-1 Flips the Switch on Eomes
Stable IL-10: A New Therapeutic that Promotes Tumor Immunity
CTLA4Ig: Bridging the Basic Immunology with Clinical Application
Presentation transcript:

Cell Death in the Maintenance and Abrogation of Tolerance: The Five Ws of Dying Cells  Thomas S. Griffith, Thomas A. Ferguson  Immunity  Volume 35, Issue 4, Pages 456-466 (October 2011) DOI: 10.1016/j.immuni.2011.08.011 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 Proposed Mechanism of Tolerance or Immunity Induced by Naive or Activated Apoptotic T Cells Left: Induction of tolerance by naive apoptotic T cells. Naive apoptotic T cells are taken up by DCs, which remain in an immature state. The antigens derived from these apoptotic T cells are cross-presented on MHC class I to CD8+ T cells in the absence of costimulatory molecules and CD4+ T cell help. These “helpless” CD8+ T cells upregulate TRAIL expression and then go on to suppress subsequent immune responses mediated by CD4+ T cells. Right: Induction of immunity by activated apoptotic T cells. CD154-expressing, activated apoptotic T cells activate DCs to upregulate costimulatory molecules (CD80, CD86) and produce proinflammatory cytokines such as IL-12. Antigens derived from the activated apoptotic T cells are cross-presented on MHC class I and directly presented on MHC class II on matured DCs, resulting in the priming of both CD8+ and CD4+ T cells. Consequently, the proinflammatory cytokines and CD4+ T cell help the CD8+ T cells to fully differentiate into effector CTL instead of a helpless, TRAIL-expressing, CD8+ Treg cells. Immunity 2011 35, 456-466DOI: (10.1016/j.immuni.2011.08.011) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 Predicting the Immunological Outcome via the Five Ws Each petal represents one of the five Ws and contains some of the factors considered in this review. The color gradient indicates a spectrum from tolerogenic (blue) to immunogenic (red). It is important to note that any element in a particular petal may be linked to any element in the other petals, resulting in a very large number of potential permutations. For example, a resting (when) lymphocyte (who) induced to die during sepsis (why) releases IL-10 (what) and is then engulfed by a splenic CD8α+ DC (where) and will induce immune tolerance via a helpless CD8+ T cell that makes TRAIL (how). Also consider another example: an apoptotic (when) normal tissue cell (who) infected with a virus (why) releases reduced HMGB1 (what) as it dies. The infected apoptotic cell is then engulfed by a CD8α+ DC in the skin (where), leading to cross-priming and activation of virus-specific CTL-mediated immunity (how). Immunity 2011 35, 456-466DOI: (10.1016/j.immuni.2011.08.011) Copyright © 2011 Elsevier Inc. Terms and Conditions